Gunzburg announced the start of recruitment of children from six years old for vaccine trials

Gunzburg: in 20 days Russia will start recruiting children aged 6-11 for vaccine trials

In less than three weeks, Russia will begin recruiting children aged six and over for vaccination. In Russia, more than 10 thousand adolescents over the age of 12 have already been vaccinated, and no side effects worthy of attention have been found in them.

In Russia, in about 20 days, the selection of children aged 6 to 11 years will begin to study the “children’s” vaccine against coronavirus “Sputnik M”, said the head of the Gamaleya center Alexander Gintsburg “Russia-24”, reports TASS.

“We received permission to conduct clinical trials in the age group from 6 to 11 years. Literally today, we received the necessary funding, which allowed us to announce a competition for an organization that will be in direct contact with medical centers, recruit test children and conduct all research related to clinical trials, ”said the scientist.

The center intends to announce a competition for an organization that will recruit test children and conduct the research itself. It is planned that 1.1 thousand volunteers will take part in the research.

Funding for clinical trials was provided by the government. They received a subsidy in the amount of 305.5 million rubles. corresponding order Prime Minister Mikhail Mishustin signed last week. The money is allocated from the government’s reserve background.

Now in Russia, children aged 12 to 17 inclusive are already being vaccinated with the “children’s” vaccine “Sputnik M” as part of trials. Vaccination of adolescents aged 12 to 15 years is carried out only with the consent of their parents or guardians, and from 15 years of age and older – with their own written informed voluntary consent. According to Gunzburg, 10,000 children among older adolescents have already been vaccinated. “Everything, according to the Ministry of Health, is very good in the sense that there are no side effects that would merit attention,” said the head of the Gamaleya center.